Amgen (AMGN) Tepezza Receives Approval In Japan For The Treatment Of Active Thyroid Eye Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Amgen (AMGN) Tepezza Receives Approval In Japan For The Treatment Of Active Thyroid Eye Disease
Amgen Inc (NASDAQ: AMGN) Delayed: 344.72 +7.12 (2.11%)
Previous Close $337.60    52 Week High $176.85 
Open $337.65    52 Week Low $133.64 
Day High $345.11    P/E 51.92 
Day Low $337.60    EPS $6.64 
Volume 2,520,731